Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
77 studies found for:    Chest CT Scan | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Condition: Healthy Subjects
Intervention:
22 Not yet recruiting Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
Conditions: Stage IIB Esophageal Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIC Esophageal Cancer
Interventions: Drug: Ferumoxytol;   Procedure: Magnetic Resonance Imaging;   Device: Magnetic Resonance Imaging;   Device: PET/CT
23 Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Drug: 18F-Fluoromisonidazole;   Drug: Carboplatin;   Procedure: Computed Tomography;   Radiation: External Beam Radiation Therapy;   Drug: Fludeoxyglucose F-18;   Radiation: Image-Guided Adaptive Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography
24 Recruiting PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
Condition: Immune Reconstitution Inflammatory Syndrome
Intervention:
25 Recruiting Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Condition: Systemic Lupus Erthematosus
Interventions: Radiation: PET/CT;   Drug: Pioglitazone;   Procedure: Vascular function studies
26 Recruiting Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Procedure: Computed Tomography;   Drug: Docetaxel;   Radiation: Fludeoxyglucose F-18;   Drug: Gemcitabine Hydrochloride;   Drug: Pemetrexed Disodium;   Procedure: Positron Emission Tomography
27 Recruiting SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
Conditions: Lung Carcinoma;   Malignant Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
28 Recruiting 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Conditions: Lung Carcinoma;   Solitary Pulmonary Nodule;   Cigarette Smoking Behavior
Interventions: Procedure: Computed Tomography;   Radiation: fluorodeoxyglucose F-18;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography (PET)
29 Recruiting FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Conditions: Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Radiation: Radiation Therapy;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
30 Recruiting Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF
Condition: Cystic Fibrosis
Intervention:
31 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
32 Recruiting Imaging Techniques in CT: Technical Development
Condition: Healthy Volunteers
Intervention:
33 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
Intervention:
34 Recruiting 18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: B-Cell Neoplasm;   Estrogen Receptor Negative;   HER2/Neu Negative;   Metastatic Renal Cell Cancer;   Progesterone Receptor Negative;   Stage III Mesothelioma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Triple-Negative Breast Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging
35 Recruiting Links Between Inflammation and Cardiometabolic Diseases
Conditions: Diabetes Mellitus;   Cardiovascular Disease;   Healthy Volunteer;   Inflammation
Intervention:
36 Unknown  The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina
Condition: Angina
Intervention:
37 Recruiting Cross-sectional Characterization of Idiopathic Bronchiectasis
Condition: Infection
Intervention:
38 Recruiting Cardiovascular Disease Screening
Conditions: Congenital Heart Disease;   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction;   Acquired Heart Disease
Intervention:
39 Recruiting Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
Condition: Acute Myeloid Leukemia
Intervention:
40 Recruiting LMB-2 to Treat Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Intervention: Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years